Skip to main content
. 2023 Oct 2;13:1185738. doi: 10.3389/fonc.2023.1185738

Figure 3.

Figure 3

Illustrative case using image-based modeling to predict intratumoral T-cell abundance (A) before and (B) after the initiation of immunotherapy. Serial predictions over time may aid in the evaluation of novel immunotherapies, as treatment-responsive patients may go undetected with traditional methods of clinical trial assessment.